Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To determine the comparability of the safety and efficacy of Imiquimod Cream, 3.75% and Zyclara (imiquimod) Cream, 3.75% (the reference listed drug) in subjects with actinic keratosis (AK) of the face or balding scalp. It will also be determined whether the efficacy of each of the two active treatments is superior to that of the Vehicle cream.
Epistemonikos ID: 1a87f5bc6c9eb13907e126195de8d49dd35f2fc6
First added on: May 11, 2024